These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4904576)

  • 41. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
    Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
    Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
    Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
    Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
    Inamoto Y; Suzuki R; Kuwatsuka Y; Yasuda T; Takahashi T; Tsujimura A; Sugimoto K; Oba T; Terakura S; Atsuta Y; Murata M; Ito M; Kodera Y; Miyamura K
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Immunologic problems in allogenic and autologous bone marrow transplantation].
    Schwenke H; Helbig W; Kubel M; Schultze W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(2):217-23. PubMed ID: 6208106
    [No Abstract]   [Full Text] [Related]  

  • 45. [Immunosuppressive effect of histone on the model of skin transplantation. Comparative studies with cyclophosphamide].
    Gillissen G
    Z Gesamte Exp Med Einschl Exp Chir; 1970 Aug; 152(4):335-51. PubMed ID: 4930364
    [No Abstract]   [Full Text] [Related]  

  • 46. Durable remission of Sézary syndrome after unrelated bone marrow transplantation by reduced-intensity conditioning.
    Kahata K; Hashino S; Takahata M; Fujisawa F; Kondo T; Kobayashi S; Fujita Y; Shimizu H; Imamura M; Asaka M
    Acta Haematol; 2008; 120(1):14-8. PubMed ID: 18716396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia.
    Kang HJ; Shin HY; Choi HS; Ahn HS
    Bone Marrow Transplant; 2004 Dec; 34(11):939-43. PubMed ID: 15489866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants.
    Hallemeier C; Girgis M; Blum W; Brown R; Khoury H; Goodnough LT; Vij R; Devine S; Wehde M; Postma S; Lin HS; Dipersio J; Adkins D
    Biol Blood Marrow Transplant; 2004 May; 10(5):310-9. PubMed ID: 15111930
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
    Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
    J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bone marrow transplantation for patients with Fanconi anemia: reduced doses of cyclophosphamide without irradiation as conditioning.
    Medeiros C; Zanis-Neto J; Pasquini R
    Bone Marrow Transplant; 1999 Oct; 24(8):849-52. PubMed ID: 10516695
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of thiotepa in allogeneic bone marrow transplantation for genetic diseases.
    Rosales F; Peylan-Ramu N; Cividalli G; Varadi G; Or R; Naparstek E; Slavin S; Nagler A
    Bone Marrow Transplant; 1999 May; 23(9):861-5. PubMed ID: 10338039
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relapse of chronic myeloid leukemia (CML) in lymphoid crisis after allogeneic bone marrow transplantation for CML in chronic phase with busulfan plus cyclophosphamide regimen.
    Takami A; Chuhjo T; Nakao S
    Haematologica; 2002 Jun; 87(6):659-61. PubMed ID: 12031925
    [No Abstract]   [Full Text] [Related]  

  • 53. Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin.
    Kröger N; Zabelina T; Renges H; Krüger W; Kordes U; Rischewski J; Schrum J; Horstmann M; Ayuk F; Erttmann R; Kabisch H; Zander AR
    Ann Hematol; 2002 Nov; 81(11):627-31. PubMed ID: 12454700
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclophosphamide regimens in rhesus monkey with and without marrow infusion.
    Storb R; Buckner CD; Dillingham LA; Thomas ED
    Cancer Res; 1970 Aug; 30(8):2195-203. PubMed ID: 4990004
    [No Abstract]   [Full Text] [Related]  

  • 55. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
    Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR
    Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Engraftment markers in allogenic bone marrow graft].
    Ribera JM; Feliu E
    Med Clin (Barc); 1989 Apr; 92(16):612-4. PubMed ID: 2664377
    [No Abstract]   [Full Text] [Related]  

  • 57. Amelioration of the side effects of cyclophosphamide.
    Hussey JL; Kisken WA
    Surg Forum; 1970; 21():109-11. PubMed ID: 4328377
    [No Abstract]   [Full Text] [Related]  

  • 58. Brief communication: Effects of chronic cyclophosphamide and methotrexate treatment on skin allograft survival in mice and rats.
    Kripke ML; Steinmuller D; Harris CC; Lofgreen PE; Eichwald EJ
    J Natl Cancer Inst; 1973 Oct; 51(4):1355-8. PubMed ID: 4583376
    [No Abstract]   [Full Text] [Related]  

  • 59. [Wound healing following tooth extraction after cyclophosphamide administration. Histological study in rats].
    Furuse TA; De Castro AL; Okamoto T; Pinto Rdos S
    Rev Fac Odontol Aracatuba; 1974; 3(2):197-205. PubMed ID: 4535892
    [No Abstract]   [Full Text] [Related]  

  • 60. Bioassay and relative cytotoxic potency of cyclophosphamide metabolites generated in vitro and in vivo.
    Sladek NE
    Cancer Res; 1973 Jun; 33(6):1150-8. PubMed ID: 4718666
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.